Gold as a Possible Alternative to Platinum-Based Chemotherapy for Colon Cancer Treatment
- PMID: 31195711
- PMCID: PMC6628079
- DOI: 10.3390/cancers11060780
Gold as a Possible Alternative to Platinum-Based Chemotherapy for Colon Cancer Treatment
Abstract
Due to the increasing incidence and high mortality associated with colorectal cancer (CRC), novel therapeutic strategies are urgently needed. Classic chemotherapy against CRC is based on oxaliplatin and other cisplatin analogues; however, platinum-based therapy lacks selectivity to cancer cells and leads to deleterious side effects. In addition, tumor resistance to oxaliplatin is related to chemotherapy failure. Gold(I) derivatives are a promising alternative to platinum complexes, since instead of interacting with DNA, they target proteins overexpressed on tumor cells, thus leading to less side effects than, but a comparable antitumor effect to, platinum derivatives. Moreover, given the huge potential of gold nanoparticles, the role of gold in CRC chemotherapy is not limited to gold(I) complexes. Gold nanoparticles have been found to be able to overcome multidrug resistance along with reduced side effects due to a more efficient uptake of classic drugs. Moreover, the use of gold nanoparticles has enhanced the effect of traditional therapies such as radiotherapy, photothermal therapy, or photodynamic therapy, and has displayed a potential role in diagnosis as a consequence of their optic properties. Herein, we have reviewed the most recent advances in the use of gold(I) derivatives and gold nanoparticles in CRC therapy.
Keywords: colorectal cancer; gold nanoparticles; gold(I) complexes; photodynamic therapy; photothermal therapy; radiotherapy; reactive oxygen species; theragnosis; thioredoxin reductase.
Conflict of interest statement
Authors declare no conflict of interest.
Figures









Similar articles
-
Beyond platinums: gold complexes as anticancer agents.Anticancer Res. 2014 Jan;34(1):487-92. Anticancer Res. 2014. PMID: 24403506 Review.
-
A Combination of Rosa Canina Extracts and Gold Complex Favors Apoptosis of Caco-2 Cells by Increasing Oxidative Stress and Mitochondrial Dysfunction.Antioxidants (Basel). 2019 Dec 24;9(1):17. doi: 10.3390/antiox9010017. Antioxidants (Basel). 2019. PMID: 31878141 Free PMC article.
-
Platinum-Coated Gold Nanorods: Efficient Reactive Oxygen Scavengers That Prevent Oxidative Damage toward Healthy, Untreated Cells during Plasmonic Photothermal Therapy.ACS Nano. 2017 Jan 24;11(1):579-586. doi: 10.1021/acsnano.6b06651. Epub 2017 Jan 3. ACS Nano. 2017. PMID: 28029783
-
Neuropilin-1-targeted gold nanoparticles enhance therapeutic efficacy of platinum(IV) drug for prostate cancer treatment.ACS Nano. 2014 May 27;8(5):4205-20. doi: 10.1021/nn500152u. Epub 2014 Apr 18. ACS Nano. 2014. PMID: 24730557
-
DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.Drug Resist Updat. 2006 Jun;9(3):111-22. doi: 10.1016/j.drup.2006.05.002. Epub 2006 Jun 21. Drug Resist Updat. 2006. PMID: 16790363 Review.
Cited by
-
Synthesis and Systematic Investigation of Lepidiline A and Its Gold(I), Silver(I), and Copper(I) Complexes Using In Vitro Cancer Models and Multipotent Stem Cells.ACS Omega. 2024 Jul 15;9(29):32226-32234. doi: 10.1021/acsomega.4c05020. eCollection 2024 Jul 23. ACS Omega. 2024. PMID: 39072085 Free PMC article.
-
Advances in the Mechanistic Understanding of Iron Oxide Nanoparticles' Radiosensitizing Properties.Nanomaterials (Basel). 2023 Jan 2;13(1):201. doi: 10.3390/nano13010201. Nanomaterials (Basel). 2023. PMID: 36616111 Free PMC article.
-
Gold (III) Derivatives in Colon Cancer Treatment.Int J Mol Sci. 2022 Jan 10;23(2):724. doi: 10.3390/ijms23020724. Int J Mol Sci. 2022. PMID: 35054907 Free PMC article. Review.
-
Triethylphosphinegold(I) Complexes with Secnidazole-Derived Thiosemicarbazones: Cytotoxic Activity against HCT-116 Colorectal Cancer Cells under Hypoxia Conditions.ACS Omega. 2020 Feb 6;5(6):2939-2946. doi: 10.1021/acsomega.9b03778. eCollection 2020 Feb 18. ACS Omega. 2020. PMID: 32095716 Free PMC article.
-
Gold complex QB1561 suppresses drug-resistant cancer cells by inhibiting TrxR and mitochondrial respiratory function.Front Pharmacol. 2025 Feb 24;16:1560880. doi: 10.3389/fphar.2025.1560880. eCollection 2025. Front Pharmacol. 2025. PMID: 40066335 Free PMC article.
References
-
- Mármol I., Quero J., Rodriguez Yoldi M.J. Modifiable and non-modifiable risk factors of colorectal cancer. In: Duncan L.T., editor. Advances in Health and Disease. 1st ed. Volume 7. Nova Science Publishers, Inc.; New York, NY, USA: 2018. pp. 67–116.
-
- Lee M.M., MacKinlay A., Semira C., Schieber C., Jimeno Yepes A.J., Lee B., Wong R., Hettiarachchige C.K.H., Gunn N., Tie J., et al. Stage-based Variation in the Effect of Primary Tumor Side on All Stages of Colorectal Cancer Recurrence and Survival. Clin. Colorectal Cancer. 2018;17:e569–e577. doi: 10.1016/j.clcc.2018.05.008. - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources